Crystals that form when urine chemistry tips past saturation — and the body must pass what chemistry built.
Kidney stones (nephrolithiasis) are hard mineral deposits that form when urine becomes supersaturated — too little water carrying too much dissolved mineral, the same chemistry that rings a kettle with limescale. Roughly 1 in 11 Americans will form a stone; among those who form one, half will form another within 5–7 years without prevention; and passage is, by broad consensus, among the most painful experiences in medicine. The modern message is unusually concrete: stone prevention is the most measurable prevention in this library — target urine volume, a 24-hour urine chemistry, the stone's own composition — and the single most powerful intervention is almost embarrassingly simple: more fluid, every day, forever.

Urine is a solution of calcium, oxalate, uric acid, citrate, and other ions, and stone formation is solution chemistry: below saturation, minerals stay dissolved; above it, crystals nucleate, grow, and aggregate. Three factors tip the balance. Concentration — the master variable: low urine volume supersaturates every mineral at once (the kettle's dry boil). Chemistry — acidic urine favors uric acid and calcium-oxalate stones; citrate is the body's built-in inhibitor that binds calcium and keeps it in solution. Templates and inhibitors — urine contains both crystal-growth promoters and inhibitors; the 24-hour urine test measures the whole contest.
Four chemistries account for nearly all stones, and each changes prevention: calcium oxalate (~80%) — the default; calcium phosphate (~10%, favored by alkaline urine); uric acid (~10%, acidic urine — the gout-adjacent chemistry, soluble in alkaline urine and genuinely dissolvable); and struvite (infection stones — treated as infections, not chemistry). Cystine stones are the rare genetic form. The stone you passed is the diagnosis: analysis costs little and redirects everything — which is why urology asks patients to strain and save.
The most important epidemiological fact in stone medicine: without preventive measures, roughly half of stone formers recur within 5–7 years — and the second stone arrives in the same person, through the same chemistry, that the first stone had already mapped. The first stone event is, in effect, a chemistry experiment the body ran on itself and published the results of.
Modern prevention reads those results: the stone analysis names the mineral; the 24-hour urine chemistry measures volume, calcium, oxalate, uric acid, citrate, and sodium — the exact levers Chapter 4 works. Studies of structured prevention (fluid targets, targeted diet, citrate therapy where indicated) show meaningful recurrence reduction. The gap between the 50% untreated recurrence and what measured prevention achieves is this page's entire reason for existing.
Two numbers anchor stone prevention. First: urine volume ≥2.5 liters daily — the target that reduces recurrence substantially in trials, and which typically means drinking ~3 liters of fluid a day (more in heat and exercise). It is measurable: the urine should run pale, and the volume target converts 'drink more water' from a slogan into a number. Second: sodium under ~2,300 mg/day — dietary sodium forces urinary calcium excretion; cutting salt is a calcium-stone treatment. Both numbers plus stone analysis plus the 24-hour urine are the evaluation worth requesting after any stone event. And with a first stone, one more question matters: was it really your first? Silent stones and passed fragments often rewrite the history.
Passing a stone means surviving three natural narrowings of the ureter — including one where it enters the bladder, the size of a pencil lead. The stone may be 2–4 mm; the door is often 1–3. The pain is not the stone's sharpness alone — it is the ureter, a muscular tube, seizing against a blockade.